The authors investigated a DMPK-promoter silencing strategy using CRISPR interference as a new alternative approach. Different sgRNAs targeting the DMPK promoter were evaluated in m yotonic dystrophy type 1 patient muscle cells.
[Molecular Therapy – Nucleic Acids]
